» Authors » Severine Martin-Lanneree

Severine Martin-Lanneree

Explore the profile of Severine Martin-Lanneree including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 534
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lailler C, Didelot A, Garinet S, Berthou H, Sroussi M, De Reynies A, et al.
Oncogene . 2024 Aug; 43(37):2781-2794. PMID: 39147880
Patients with EGFR-mutated non-small cell lung cancer (NSCLC) benefit from treatment with tyrosine kinase inhibitors (TKI) targeting EGFR. Despite improvements in patient care, especially with the 3rd generation TKI osimertinib,...
2.
Mouillet-Richard S, Martin-Lanneree S, Le Corre D, Hirsch T, Ghazi A, Sroussi M, et al.
Oncogene . 2022 Aug; 41(38):4397-4404. PMID: 35962130
The cellular prion protein PrP partners with caveolin-1 (CAV1) in neurodegenerative diseases but whether this interplay occurs in cancer has never been investigated. By leveraging patient and cell line datasets,...
3.
Boisteau E, Lespagnol A, de Tayrac M, Corre S, Perrot A, Rioux-Leclercq N, et al.
Clin Res Hepatol Gastroenterol . 2022 Feb; 46(5):101888. PMID: 35189426
Background: Low miR-31-3p expression was identified as predictive of anti-EGFR efficacy in RAS-wt mCRC. Primary tumor side was also proposed as a predictive factor of anti-EGFR benefit. This retrospective multicentric...
4.
Le Corre D, Ghazi A, Balogoun R, Pilati C, Aparicio T, Martin-Lanneree S, et al.
EBioMedicine . 2019 Aug; 46:94-104. PMID: 31377347
Background: Comprehensive transcriptomic analyses have shown that colorectal cancer (CRC) is heterogeneous and have led to the definition of molecular subtypes among which the stem-cell, mesenchymal-like group is associated with...
5.
Dumas P, Naudin C, Martin-Lanneree S, Izac B, Casetti L, Mansier O, et al.
Haematologica . 2019 Mar; 104(10):2017-2027. PMID: 30923103
Internal tandem duplication in Fms-like tyrosine kinase 3 (FLT3-ITD) is the most frequent mutation observed in acute myeloid leukemia (AML) and correlates with poor prognosis. FLT3 tyrosine kinase inhibitors are...
6.
Hirsch T, Martin-Lanneree S, Reine F, Hernandez-Rapp J, Herzog L, Dron M, et al.
Mol Neurobiol . 2018 Jul; 56(3):2159-2173. PMID: 29998397
Among the ever-growing number of self-replicating proteins involved in neurodegenerative diseases, the prion protein PrP remains the most infamous for its central role in transmissible spongiform encephalopathies (TSEs). In these...
7.
Ramon L, David C, Fontaine K, Lallet E, Marcaillou C, Martin-Lanneree S, et al.
Biomark Insights . 2018 Mar; 13:1177271918763357. PMID: 29568219
MiR-31-3p expression has been shown to be a predictive biomarker for response to anti-epithelial growth factor receptor therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC). To aid in...
8.
Hirsch T, Martin-Lanneree S, Mouillet-Richard S
Prog Mol Biol Transl Sci . 2017 Aug; 150:1-34. PMID: 28838656
Although initially disregarded compared to prion pathogenesis, the functions exerted by the cellular prion protein PrP have gained much interest over the past two decades. Research aiming at unraveling PrP...
9.
Martin-Lanneree S, Halliez S, Hirsch T, Hernandez-Rapp J, Passet B, Tomkiewicz C, et al.
Stem Cells . 2016 Sep; 35(3):754-765. PMID: 27641601
The prion protein is infamous for its involvement in a group of neurodegenerative diseases known as Transmissible Spongiform Encephalopathies. In the longstanding quest to decipher the physiological function of its...
10.
Halliez S, Martin-Lanneree S, Passet B, Hernandez-Rapp J, Castille J, Urien C, et al.
Sci Rep . 2015 Dec; 5:17146. PMID: 26679898
Although conversion of the cellular form of the prion protein (PrP(C)) into a misfolded isoform is the underlying cause of prion diseases, understanding PrP(C) physiological functions has remained challenging. PrP(C)...